Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures +0.52%, Hang Seng Futures +0.51%, ASX SPI 200 +0.61%, S&P Futures (0.10%)

May 26 ,2024

  • Synopsis:

    • Asian markets set for positive start to Monday trade. Nikkei, Hang Seng and ASX futures all pointing to opening gains. S&P 500 futures a touch lower. Australian bond yields down 1-2 bp following Treasury curve bull flattening on Friday. FX markets quiet following range-bound dollar price action on Friday. Gold steady near two-week low. Crude little changed following Friday rebound. Bitcoin pulling back from earlier highs.

    • Markets begin new week on back foot as hawkish-leaning Fedspeak coupled with better-than-expected US macro data led to a dialing back of September Fed rate cut expectations. Meanwhile, China equities nursing heavy losses (Hang Seng suffered worst week since January), as analysts point to overbought conditions and still-weak economic and property fundamentals. Developments overshadowed latest bout of AI-related optimism fueled by NVDA's blowout results.

    • On geopolitical front, USTR announced reimposition of US tariffs on import of hundreds of Chinese goods, expanding upon recent Biden administration tariff hike on Chinese EVs and other imports. Leaders of China, Japan and South Korea holding summit for first time since 2019. China ended military drills around Taiwan and warned against outside intervention. However, tensions may remain elevated as US lawmakers visit Taiwan this week.

  • Pre-open Company News:

    • 542752.IN -- Affle (India) upgraded to buy from accumulate at Dolat Capital Markets

    • 1155.MK -- Malayan Banking upgraded to buy from hold at Affin Hwang Investment Bank

    • 590071.IN -- Sundaram Finance reports Q4 standalone EPS INR45.57 vs year-ago INR28.47

    • 884.HK -- CIFI Holdings makes further progress with lenders, to proceed with negotiations over definitive documentation

    • 532843.IN -- Fortis Healthcare downgraded to neutral from overweight at JPMorgan

    • 2454.TT -- MediaTek upgraded to buy from neutral at UBS

    • 532898.IN -- Power Grid Corp. of India downgraded to sell from hold at Investec

    • 3635.JP -- Koei Tecmo Holdings downgraded to neutral from buy at Nomura

    • 068270.KS -- Celltrion upgraded to buy from outperform at Kiwoom Securities

    • 532898.IN -- Power Grid Corp. of India upgraded to accumulate from reduce at Elara Capital

    • 600276.CH -- Jiangsu Hengrui Pharmaceuticals' subsidiaries receive NMPA approval for clinical trials of three injectable cancer drugs

    • 4528.JP -- Ono Pharmaceutical downgraded to sell from neutral at Citi

    • 532733.IN -- Sun TV Network downgraded to reduce from buy at Dolat Capital Markets

    • 600161.CH -- Beijing Tiantan Biological Products initiated overweight at Morgan Stanley

    • 002790.KS -- AmorePacific Group upgraded to buy from sell at CLSA

  • On Deck:

    • Hong Kong:

      • Earnings:

        • CSPC Pharmaceutical Group (1093.HK), Alibaba Health Information Technology (241.HK)

    • Japan:

      • Economic:

        • 14:00 JST: Leading Index (Final); consensus

    • New Zealand:

      • Earnings:

        • Arvida Group (ARV.NZ), Goodman Property Trust (GMT.NZ), Serko (SKO.NZ), Tower (TWR.NZ)

    • India:

      • Earnings:

        • National Aluminium (532234.IN), NATCO Pharma (524816.IN), Life Insurance Corp. of India (543526.IN)

  • Market Data:

    • Gold (Jun 24): +$5.50 or +0.24% to $2340.00

    • WTI Crude (Jul 24): +$0.06 or +0.08% to $77.78

    • $-¥: (0.08) or (0.05%) to 156.9000

    • $-KRW: (1.83) or (0.13%) to 1365.7000

    • A$-$: (0.00) or (0.05%) to 0.6624

    • $-INR: (0.00) or (0.00%) to 83.0585

    • $-CNY: (0.00) or (0.01%) to 7.2423

  • If you would like to receive the Asian Market Preview daily, please search for Asia Pre-Market Updates in Alert Manager.

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE